Literature DB >> 15664492

In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.

Semiha Solak, Ayşe Willke, Onder Ergönül, Emin Tekeli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664492     DOI: 10.1016/j.ijantimicag.2004.11.005

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  4 in total

1.  Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  Glenn A Pankuch; Gengrong Lin; Harald Seifert; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

2.  Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.

Authors:  Vera Lúcia Dias Siqueira; Rosilene Fressatti Cardoso; Katiany Rizzieri Caleffi-Ferracioli; Regiane Bertin de Lima Scodro; Maria Aparecida Fernandez; Adriana Fiorini; Tania Ueda-Nakamura; Benedito Prado Dias-Filho; Celso Vataru Nakamura
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

3.  Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.

Authors:  Vanessa E Rees; Rajbharan Yadav; Kate E Rogers; Jürgen B Bulitta; Veronika Wirth; Antonio Oliver; John D Boyce; Anton Y Peleg; Roger L Nation; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

4.  Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model.

Authors:  Hajira Bilal; Phillip J Bergen; Jessica R Tait; Steven C Wallis; Anton Y Peleg; Jason A Roberts; Antonio Oliver; Roger L Nation; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.